tiprankstipranks
Trending News
More News >

GB:CURE ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Strong Buy
16Bullish
3Neutral
3Bearish
Oscillators
Neutral
4Bullish
3Neutral
3Bearish
Moving Averages
Strong Buy
12Bullish
0Neutral
0Bearish
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Moving Averages Convergence Divergence (MACD) indicator is 0.18, suggesting VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 20-Day exponential moving average is 19.46, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-Day exponential moving average is 19.09, making it a Buy.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Pivot Points

Jun 30, 2025, 01:37 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.63
19.63
19.63
19.63
19.63
19.63
19.63
Fibonacci
19.63
19.63
19.63
19.63
19.63
19.63
19.63

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Moving Averages

Jun 30, 2025, 01:37 AM
Period
Simple
Exponential
MA5
19.53Buy
19.62Buy
MA10
19.51Buy
19.56Buy
MA20
19.59Buy
19.46Buy
MA50
18.85Buy
19.09Buy
MA100
18.84Buy
19.00Buy
MA200
19.30Buy
19.24Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 10-Day exponential moving average is 19.56, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-Day exponential moving average is 19.00, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-day simple moving average is 18.85, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-day simple moving average is 18.84, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 200-day simple moving average is 19.30, creating a Buy signal.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Technical Analysis

Jun 30, 2025, 01:37 AM
Name
Value
Action
RSI (14)
61.65
Neutral
STOCH (9,6)
90.39
Sell
STOCHRSI (14)
71.25
Neutral
MACD (12,26)
0.18
Buy
ADX (14)
17.98
Buy
Williams %R
-0.58
Sell
CCI (14)
127.20
Sell
ATR (14)
0.16
-
Ultimate Oscillator
58.11
Neutral
ROC
0.66
Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Relative Strength Index (RSI) is 61.65, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Trend Strength Indicator (ADX) is 17.98, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Commodity Channel Index (CCI) is 127.20, creating a Sell signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Price Rate of Change (ROC) is 0.66, creating a Buy signal.

FAQ

Is CURE a Buy, Hold, or Sell?
Based on CURE’s technical indicators, CURE is a Strong Buy.
    What is CURE’s RSI (14)?
    CURE’s RSI (14) is 61.65, which suggests CURE is a Neutral.
      What is CURE’s MACD?
      CURE’s MACD is 0.18, which suggests CURE is a Buy.
        What is CURE’s 5-day moving average?
        CURE’s 5-day moving average is 19.53, which suggests CURE is a Buy.
          What is CURE’s 20-day moving average?
          CURE 20-day moving average is 19.59, which suggests CURE is a Buy.
            What is CURE’s 50-day moving average?
            CURE’s 50-day moving average is 18.85, which suggests CURE is a Buy.
              What is CURE’s 200-day moving average?
              CURE’s 200-day moving average is 19.30, which suggests CURE is a Buy.
                What is CURE’s Williams % R (14)?
                CURE’s Williams % R (14) is -0.58, which suggests CURE is a Sell.
                  What is CURE’s CCI (14)?
                  CURE’s CCI (14) is 127.20, which suggests CURE is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis